The effect of the genetic polymorphisms of CYP1A1,CYP2D6, GSTM1 and GSTP1 on aromatic DNA adduct levels in the population of healthy women

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 469, Issue 2, 2000, Pages 271-277

  Grzybowska, Ewa ^a   Butkiewicz, Dorota ^a   Motykiewicz, Grazyna ^a   Chorazy, Mieczyslaw ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Aromatic DNA adducts; Genetic susceptibility; Polymorphism of metabolizing enzymes; Xenobiotics

Indexed keywords

DEBRISOQUINE 4 HYDROXYLASE; ETHOXYRESORUFIN DEETHYLASE; XENOBIOTIC AGENT;

ADULT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DETOXIFICATION; DNA ADDUCT; ENZYME POLYMORPHISM; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2D6; DNA ADDUCTS; FEMALE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; MUTAGENS; POLAND; POLYMORPHISM, GENETIC; SEASONS;

EID: 0034692616     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(00)00090-5     Document Type: Article

References (37)

1. La D.K., Swenberg J.A. DNA adducts: biological markers of exposure and potential applications to risk assessment. Mutat. Res. 365:1996;129-146.
2. Gallagher J., George M., Kohan M., Thompson C., Shank T., Lewtas J. Detection and comparison of DNA adducts after in vitro and in vivo diesel emission exposures. Environ. Health Perspect. 99:1993;225-228.
3. K. Yang, L. Airoldi, R. Pastorelli, J. Restano, M. Guanci, K. Hemminki, Aromatic DNA adducts in lymphocytes of humans working at high and low traffic density area, Chemico-Biol. Interact. (1996) 127-136.
4. 32P -postlabelling and enzyme-linked immunosorbent assay Environ. Health Perspect. 99:1993;307-309.
5. 32P -postlabelling assay Carcinogenesis. 10:1991;503-508.
6. Ovrebo S., Haugen A., Phillips D.H., Hewer A. Detection of polycyclic aromatic hydrocarbon DNA adducts in white blood cells from coke oven workers: correlation with job categories. Cancer Res. 52:1992;1510-1514.
7. Lewtas J., Mumford J., Everson R.B., Hulka B., Wilcosky T., Kozumbo W., Thompson C., George H., Dobias L., Sram R., Li X., Gallagher J. Comparison of DNA adducts from exposure to complex mixtures in various human tissues and experimental systems. Environ. Health Perspect. 99:1993;89-97.
8. Hemminki K., Grzybowska E., Chorazy M., Twardowska-Saucha K., Sroczynski J.W., Putman K.L., Randerath K., Phillips D.H., Hewer A., Santella R.M., Young T.L., Perera F.P. DNA adducts in humans environmentally exposed to aromatic compounds in an industrial area of Poland. Carcinogenesis. 11:1990;1229-1231.
9. Vineis P. Molecular epidemiology: low dose carcinogens and genetic susceptibility. Int. J. Cancer. 71:1997;1-3.
10. d'Errico A., Taioli E., Chen X., Vineis P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers. 1:1996;149-173.
11. Hirvonen A. Genetic factors in individual responses to environmental exposures. JOEM. 37:1995;37-43.
12. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Ogreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
13. Hayashi S., Watanabe J., Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IAI and μ-class glutathione S transferase genes. Jpn. J. Cancer Res. 83:1992;666-870.
14. Nakashi K., Imai K., Hayashi S., Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette smoke dose in Japanese population. Cancer Res. 53:1993;2994-2999.
15. Perera F.P., Whyatt R.M. Biomarkers and molecular epidemiology in mutation/cancer research. Mutat. Res. 313:1994;117-129.
16. Harris C.C., Vahakangas K., Newman M.J., Trivers G.E., Shamsuddin A., Sinopoli N., Mann D.L., Wright W.E. Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc. Natl. Acad. Sci. USA. 82:1985;6672-6676.
17. Perera F.P., Hemminki K., Young T.L., Brenner D., Kelly G., Santella R.M. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res. 48:1988;2288-2291.
18. Butkiewicz D., Grzybowska E., Hemminki K., Øvrebø S., Haugen A., Motykiewicz G., Chorazy M. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms. Mutat. Res. 415:1998;97-108.
19. Butkiewicz D., Grzybowska E., Phillips D.H., Hemminki K., Chorazy M. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear cells. Environ. Mol. Mutagen. 25:2000;99-105.
20. Mumford J.L., Lee X., Lewtas J., Young T.L., Santella R.M. DNA adducts as biomarkers for assessing exposure to polycyclic aromatic hydrocarbons in tissues from Xuan Wei women with high exposure to coal combustion emissions and high lung cancer mortality. Environ. Health Perspect. 99:1993;83-87.
21. Motykiewicz G., Michalska J., Pendzich J., Malusecka E., Strózyk M., Kalinowska E., Butkiewicz D., Mielżyńska D., Midro A., Santella R.M., Choraży M. A molecular epidemiology study in women from Upper Silesia. Poland Toxicol. Lett. 96:1998;195-202.
22. Grzybowska E., Hemminki K., Szeliga J., Chorazy M. Seasonal variation of aromatic-DNA adducts in human mononuclear white blood cells and granulocytes. Carcinogenesis. 14:1993;2523-2526.
23. 32P -postlabelling test for structurally diverse DNA adducts Carcinogenesis. 7:1986;1543-1551.
24. Harries L.W., Stubbins M.J., Forman D., Howard G.C.W., Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferase π locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 18:1997;641-644.
25. Shields P.G., Bowman E.D., Harrington A.M., Doan V.T., Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 53:1993;3486-3492.
26. Heim M., Meyer U.A. Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification. Lancet. 336:1990;529-532.
27. Kato S., Bowman E.D., Harrington A.M., Blomeke B., Shields P.G. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl. Cancer Inst. 87:1995;902-907.
28. Mollerup S., Ryberg D., Hewer A., Phillips D.H., Haugen A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res. 59:1999;3317-3320.
29. Thomsen J.S., Wang X., Hines R.N., Safe S. Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis. 15:1994;933-937.
30. Hu X., Ji X., Srivastava S.K., Xia H., Awasthi S., Nanduri B., Awasthi Y.C., Zimniak P., Singh S.V. Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Arch. Biochem. Biophys. 345:1997;32-38.
31. Hu X., Pal A., Krzeminski J., Amin S., Awasthi Y.C., Zimniak P., Singh S.V. Specificities of human glutathione S-transferase isozymes toward anti-diol epoxides of methylchrysenes. Carcinogenesis. 19:1998;1685-1689.
32. Antilla S., Hirvonen A., Vainio H., Husgafvel-Pursiainen K., Hayes J.D., Ketterer B. Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res. 53:1993;5643-5648.
33. Kihara M., Kihara M., Noda K. Risk of smoking for squamosus and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in Japanese population. Carcinogenesis. 16:1995;2331-2336.
34. Taningher M., Malacarne D., Izzotti A., Ugolini D., Parodi S. Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat. Res. 436:1999;227-261.
35. Harris M.J., Coggan M., Langton L., Wilson S.R., Board P.G. Polymorphism of the π class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics. 8:1998;27-31.
36. Ryberg D., Hewer A., Phillips D.H., Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res. 54:1994;5801-5803.
37. Bennett W.P., Alavanja M.C., Blomeke B., Vahakangas K.H., Castren K., Welsh J.A., Bowman E.D., Khan M.A., Flieder D.B., Harris C.C. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J. Natl. Cancer Inst. 1:1999;2009-2014.